Home > Journals > Minerva Gastroenterology > Past Issues > Articles online first > Minerva Gastroenterology 2021 May 31

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Gastroenterology 2021 May 31

DOI: 10.23736/S2724-5985.21.02890-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Epidemiology and clinical course of late onset inflammatory bowel disease

Anna VIOLA 1 , Gionata FIORINO 2, Giuseppe COSTANTINO 1, Walter FRIES 1

1 Gastroenterology and Clinical Unit for Chronic Bowel Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; 2 IBD Centre, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy


PDF


With the increasing age of the general population in developed countries, the management of several chronic diseases becomes more and more complex due to comorbidities. Some, especially inflammatory bowel diseases, formerly believed to belong to the young adult population, have now been recognized as being present at disease onset also in the ageing population, representing medical challenges different from those in the younger population. In the past years, knowledge on this special older population has increased, changing initial beliefs concerning epidemiology and course of disease. In the present review, we will address the most recent evidence concerning their current incidence compared with other age groups, their clinical course, potential risk factors for the development of late-onset IBDs, associated diseases, and cancer risk beyond therapy-related neoplasias.


KEY WORDS: Crohn’s disease; Ulcerative colitis; Incidence; Disease progression; Surgery

top of page